Ragnhildstveit A

Department of Psychiatry, University of Cambridge, Cambridge, UK.

8 papers · 1 preprint · ORCID

ArticlePsilocybin

The trials of translating psilocybin treatment from research to practice.

Galindo L, Ragnhildstveit A, Illingworth BJG

Europe PMC2026
ArticlePsilocybin

Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care.

Geller JA, Pacilio R, Downey AE +4

Europe PMC2026
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUM.

Beidas Z, Ragnhildstveit A, Blackman A +8

Europe PMC2026
ArticlePsilocybin

Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial.

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2026
PreprintPsilocybin

Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial

Beidas Z, Ragnhildstveit A, Blackman A +9

Europe PMC2025
ArticleDMT

5-MeO-DMT for post-traumatic stress disorder: a real-world longitudinal case study.

Ragnhildstveit A, Khan R, Seli P +8

Europe PMC2023
ArticleKetamine

The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence.

Ragnhildstveit A, Roscoe J, Bass LC +3

Europe PMC2023
ArticlePsilocybin

Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report.

Ragnhildstveit A, Kaiyo M, Snyder MB +8

Europe PMC2023
ArticleKetamine

Ketamine as a Novel Psychopharmacotherapy for Eating Disorders: Evidence and Future Directions.

Ragnhildstveit A, Slayton M, Jackson LK +7

Europe PMC2022